Why is "Small cell" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-15 06:46:05
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Small_cell entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-15 and was most recently seen on 2026-03-15.
Wikipedia Overview
Small cells are low-powered cellular radio access nodes that have ranges from around 10 meters to a few kilometers. They are base stations with low power consumption and cost. They can provide high data rates by being deployed densely to achieve high spatial spectrum efficiency.
Read more on Wikipedia →Related Topics
- Small cell (disambiguation)
- 3GPP
- 3GPP Long Term Evolution
- 5G
- Application programming interface
- ArXiv (identifier)
- Backhaul (telecommunications)
- Beamforming
- CDMA2000
- Carrier grade
Trending Topic Today
Search Interest Perspective
-
BLiNQ Networks Launches Private 5G Small Cell Portfolio for Canada’s NCL Spectrum Band - The Fast Mode
-
Updates in Small Cell Lung Cancer - Journal of Hematology Oncology Pharmacy
-
Rare Disease Guide: Small-Cell Lung Cancer - WebMD
-
Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer - NEJM
-
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities - Wiley
-
Durvalumab Offers New Path in Small Cell Lung Cancer Care - University of Miami
-
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial - Nature
-
Immunotherapy Combo Fails to Improve Survival in Limited-Stage Small Cell Lung Cancer - Oncology News Central
-
Small cell lung cancer: from immunobiological mechanisms to clinical advances - Frontiers
-
What New Treatments Are Improving Survival in Small Cell Lung Cancer? - Cure Today
-
Crown Castle Announces Closing of Sale of Fiber and Small Cell Businesses and Updates Full Year 2026 Outlook - Crown Castle
-
I-DXd Earns FDA Priority Review in Extensive-Stage Small Cell Lung Cancer - CancerNetwork
-
YAP1 protein found to drive chemotherapy resistance in small cell lung cancer after treatment - Drug Target Review
-
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial - Nature
-
Breaking Down Treatment Advancements for Small Cell Lung Cancer - Cure Today
-
PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition - Nature
-
Eukaryote initiation factor 6 modulates small-cell lung carcinoma plasticity via the integrin-FAK signaling axis - Nature
-
Interpretable multiclassification machine learning models in predicting the extent of small cell lung cancer metastasis - Nature
-
Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progression - Nature
-
AI-powered spatial cell phenomics enhances risk stratification in non-small cell lung cancer - Nature
-
Functional synapses between neurons and small cell lung cancer - Nature
-
Reviewing the IMforte Phase 3 Data in Extensive Stage Small Cell Lung Cancer - OncLive
-
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations - Nature
-
Chemoradiation Plus Atezolizumab in Limited-Stage Small Cell Lung Cancer - The ASCO Post
-
First Line Maintenance in Extensive Stage Small Cell Lung Cancer - OncLive
-
Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesis - Nature
-
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer - NEJM
-
Duke researcher traces origins of small-cell lung cancer to basal stem cells - The Duke Chronicle
-
FDA Approves Tarlatamab for Small Cell Lung Cancer - Oncology News Central
-
Non-Small Cell Lung Cancer (NSCLC) Workup: Approach Considerations, Laboratory Studies, Chest Radiography - Medscape
-
Basal Stem Cells Identified as Origin of Small Cell Lung Cancer in Lab Models - Duke Health
-
Small cell lung cancer induces synaptic scaling to alter neuronal excitability | Communications Biology - Nature
-
Stage 3B Non-Small Cell Lung Cancer Treatments and Prognosis - Verywell Health
-
Brain metastasis from non-small cell lung cancer: crosstalk between cancer cells and tumor microenvironment components - Nature
-
New AI tool predicts whether aggressive small cell lung cancer will respond to treatment - Medical Xpress
-
In Extensive-Stage Small Cell Lung Cancer Novel Maintenance Regimen Boosts Overall Survival - The ASCO Post
-
Optimal Management of Extensive-Stage Small Cell Lung Cancer - Medscape Reference
-
How New Therapies Are Changing the Game for Small Cell Lung Cancer - Cure Today
-
RNA sequencing reveals differential expression of circular RNAs in human small cell lung cancer - Nature
-
Advances in Small Cell Lung Cancer Treatment and Survival - Yale School of Medicine
-
EMA OKs Two Treatments for Small Cell Lung Cancer - Medscape
-
Defining the limits of immunotherapy in early small-cell lung cancer - News-Medical
-
ROS1 -positive non-small cell lung cancer: from genomics to treatment decisions - Frontiers
-
UK first in nation to treat small cell lung cancer patient with new immunotherapy - Kentucky Lantern
-
FDA Grants Full Approval to Tarlatamab for Extensive-Stage Small Cell Lung Cancer - OncLive
-
Unresectable stage III non-small-cell lung cancer: state of the art and challenges - Nature
-
Immunotherapy Advances Transform Small Cell Lung Cancer Care - Cure Today
-
Extensive-stage small-cell lung cancer: new approaches on the horizon? - ESMO Daily Reporter
-
DNA methylation cooperates with genomic alterations during non-small cell lung cancer evolution - Nature
-
Pharmacists Navigate an Evolving Immunotherapy Landscape in Advanced Non–Small Cell Lung Cancer - Pharmacy Times
-
DLL3 Emerges as an Actionable Target in Small Cell Lung Cancer - Targeted Oncology
-
Small cell carcinoma of the ovary, hypercalcemic type: a mini review - Frontiers
-
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer - michiganmedicine.org
-
New Targets Emerge for Aggressive Small Cell Lung Cancer - Targeted Oncology
-
Long non-coding RNAs and signaling networks in non-small cell lung cancer: mechanistic insights into tumor pathogenesis | Cancer Gene Therapy - Nature
-
There’s Big News in the Fight Against Small-Cell Lung Cancer - AdventHealth
-
Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies - Nature
-
Genetic weakness may help target deadly small cell neuroendocrine cancers - Medical Xpress
-
Key gene behind drug resistance in small cell lung cancer identified - Medical Xpress
-
Crown Castle completes $8.5 billion sale of fiber and small cell assets, emerges as pure-play tower company - Wireless Estimator
-
Case 1: Relapsed Small Cell Lung Cancer - The ASCO Post
-
Case 3: Newly Diagnosed Limited-Stage Small Cell Lung Cancer - The ASCO Post
-
Case 2: Newly Diagnosed Extensive-Stage Small Cell Lung Cancer - The ASCO Post
-
Non-Small Cell Lung Cancer (NSCLC) Treatment: Your Options - Health: Trusted and Empathetic Health and Wellness Information
-
Macrocell vs. small cell vs. femtocell: A 5G introduction - TechTarget
-
Prognostic value of the StAN score in elderly small cell lung cancer - Nature
-
Serplulimab Earns UK Approval in Extensive-Stage Small Cell Lung Cancer - CancerNetwork
-
Advancing therapeutics in small-cell lung cancer - Nature
-
Non-Small Cell Lung Cancer (NSCLC) Report - evaluate.com
-
Advances in molecular pathology and therapy of non-small cell lung cancer | Signal Transduction and Targeted Therapy - Nature
-
Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial - The Lancet
-
Advances in small cell lung cancer classification - UT MD Anderson
-
Intrinsic electrical activity drives small-cell lung cancer progression - Nature
-
Evolutionary trajectories of small cell lung cancer under therapy - Nature
-
Tarlatamab Shows Promise for Some People with Small Cell Lung Cancer - National Cancer Institute (.gov)
-
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy - NEJM
-
Atypical Small Cell Carcinoma, a Rare Type Lung Cancer, Identified by MSK Research Team - Memorial Sloan Kettering Cancer Center
-
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer - Nature
-
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions - Wiley
-
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer - NEJM
-
What’s On the Horizon for Small Cell Lung Cancer Research? - Cure Today
-
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer - NEJM
-
Small Cell Lung Cancer Treatment & Pharmacologic Management - Cancer Therapy Advisor
-
Imfinzi Improves Survival in Small Cell Lung Cancer - National Cancer Institute (.gov)
-
Plasticity of circulating tumor cells in small cell lung cancer - Nature
-
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation - NEJM
-
Small Cell Lung Cancer: New Hope, New Challenges - ASCO Publications
-
How Non-Small Cell Lung Cancer (NSCLC) Treatment Is Improving - Yale Medicine
-
FOXA2 promotes metastatic competence in small cell lung cancer - Nature
-
New Mount Sinai Research Brings Hope for Small Cell Lung Cancer Patients - Mount Sinai
-
Small-cell lung cancer - Nature
-
Top advances of the year: Small cell lung cancer - Shields - 2025 - Cancer - Wiley
-
Toward personalized treatment approaches for non-small-cell lung cancer - Nature
-
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer - NEJM
-
Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer - NEJM
-
Molecular determinants of sotorasib clinical efficacy in KRAS - Nature
-
Fred Hutch study finds genetic driver of drug resistance in small cell lung cancer - Fred Hutchinson Cancer Center
-
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer - NEJM
-
Immunotherapy/Chemoradiotherapy for Patients With Limited-Stage Small Cell Lung Cancer - The ASCO Post
-
Treatment and survival of non-metastatic small cell carcinoma of the bladder from multiple centers in China - Nature
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.